Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

Press Release/Announcement

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

May 15, 2013

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; May 6, 2013.

This announcement describes the risk of medication mix-ups associated with the use of an incorrect nonproprietary name for a breast cancer drug.

Free full text

Related Resources From the Same Author(s)

FDA requiring color changes to Duragesic (fentanyl) pain patches to aid safety―emphasizing that accidental exposure to used patches can cause death.

October 9, 2013

Codeine use in certain children after tonsillectomy and/or adenoidectomy may lead to rare, but life-threatening adverse events or death.

February 20, 2013

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

Heparin sodium injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL medication errors.

March 22, 2010

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

May 24, 2015

Wear face masks with no metal during MRI exams.

December 16, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Related Resources

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

October 10, 2018

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

Important Warnings and Instructions for Heparin Sodium Injection (Baxter).

September 30, 2015

Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume.

May 30, 2012

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

September 29, 2010

Serious medication errors from intravenous administration of nimodipine oral capsules.

August 11, 2010

Relenza (zanamivir) inhalation powder.

March 12, 2010

Shelhigh, Inc. implantable medical devices.

May 2, 2007

See More About The Topic

Health Care Providers

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion.

Connect With Us

Sign up for Email Updates

Agency for Healthcare Research and Quality

Submit Your Innovations

Continue as a Guest

Continue Logged In

Submit Your Innovations

Continue as a Guest

Continue logged in

New Users to the PSNet site

Submit Your Training

Continue as a Guest

Continue Logged In

Submit Your Training

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your Toolkit

Continue as a Guest

Continue Logged In

Submit Your Toolkit

Continue as a Guest

Continue Logged In

New Users to the PSNet site

Submit Your WebM&M Case

Continue as a Guest

Continue Logged In

Submit Your WebM&M Case

Continue as a Guest

Already have a PSNet

Account?

New Users